Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Cohort of Patients With Refractory Metastatic Colorectal Cancer (MCRC) Treated With Bevacizumab and Everolimus

NCT00597506 is registered in ClinicalTrials.gov with Herbert Hurwitz as lead sponsor.

NCT NCT00597506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00597506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Cohort of Patients With Refractory Metastatic Colorectal Cancer (MCRC) Treated With Bevacizumab and Everolimus
Lead sponsor
Herbert Hurwitz
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
June 30, 2010
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenocarcinoma